This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, E. Articles by Locarnini, S. Search for Related Content PubMed PubMed Citation Articles by Lin, E. Articles by Locarnini, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 02 1996, 413-418, Vol 40, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo

E Lin, C Luscombe, YY Wang, T Shaw and S Locarnini
Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Victoria, Australia.

Ducks congenitally infected with duck hepatitis B virus (HBV) were treated with the antiviral guanine nucleoside analog penciclovir for 4 weeks at a dose of 10 mg/kg of body weight per day. The effects of treatment on viremia and intrahepatic viral genome replication, transcription, and translation were examined. In seven of eight penciclovir-treated ducks, viremia was barely detectable after a week of treatment. After 4 weeks of treatment, molecular hybridization studies showed that intrahepatic viral DNA, RNA, and protein levels were significantly reduced compared with those in placebo-treated controls. Synthesis of all viral replicative intermediates, including the normally persistent viral supercoiled DNA species, was inhibited by penciclovir treatment. Examination of liver tissue sections after in situ DNA hybridization or immunohistochemical staining confirmed that viral DNA and protein synthesis had been profoundly inhibited in most hepatic parenchymal cells. However, small subpopulations of cells, in particular the small bile duct epithelial cells, remained strongly positive for duck HBV antigens and DNA despite treatment. There was no evidence of toxicity associated with penciclovir therapy. This study confirms the safety and potent antihepadnaviral activity of penciclovir in vivo but indicates that further improvements in antiviral therapy will be required to completely eliminate HBV infection.

This article has been cited by other articles:

• Lee, J.-Y., Culvenor, J. G., Angus, P., Smallwood, R., Nicoll, A., Locarnini, S. (2001). Duck Hepatitis B Virus Replication in Primary Bile Duct Epithelial Cells. J. Virol. 75: 7651-7661 [Abstract] [Full Text]  
• Whalley, S. A., Murray, J. M., Brown, D., Webster, G. J.M., Emery, V. C., Dusheiko, G. M., Perelson, A. S. (2001). Kinetics of Acute Hepatitis B Virus Infection in Humans. JEM 193: 847-854 [Abstract] [Full Text]  
• Le Guerhier, F., Pichoud, C., Jamard, C., Guerret, S., Chevallier, M., Peyrol, S., Hantz, O., King, I., Trépo, C., Cheng, Y.-C., Zoulim, F. (2001). Antiviral Activity of {beta}-L-2',3'-Dideoxy-2',3'-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus. Antimicrob. Agents Chemother. 45: 1065-1077 [Abstract] [Full Text]  
• Colledge, D., Civitico, G., Locarnini, S., Shaw, T. (2000). In Vitro Antihepadnaviral Activities of Combinations of Penciclovir, Lamivudine, and Adefovir. Antimicrob. Agents Chemother. 44: 551-560 [Abstract] [Full Text]  
• Nicoll, A. J., Colledge, D. L., Toole, J. J., Angus, P. W., Smallwood, R. A., Locarnini, S. A. (1998). Inhibition of Duck Hepatitis B Virus Replication by 9-(2-Phosphonylmethoxyethyl)adenine, an Acyclic Phosphonate Nucleoside Analogue. Antimicrob. Agents Chemother. 42: 3130-3135 [Abstract] [Full Text]  
• Lin, E., Luscombe, C., Colledge, D., Wang, Y. Y., Locarnini, S. (1998). Long-Term Therapy with the Guanine Nucleoside Analog Penciclovir Controls Chronic Duck Hepatitis B Virus Infection In Vivo. Antimicrob. Agents Chemother. 42: 2132-2137 [Abstract] [Full Text]  
• Aguesse-Germon, S., Liu, S.-H., Chevallier, M., Pichoud, C., Jamard, C., Borel, C., Chu, C. K., Trépo, C., Cheng, Y.-C., Zoulim, F. (1998). Inhibitory Effect of 2'-Fluoro-5-Methyl-beta -L-Arabinofuranosyl-Uracil on Duck Hepatitis B Virus Replication. Antimicrob. Agents Chemother. 42: 369-376 [Abstract] [Full Text]